You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

No evidence of metastatic disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Tislelizumab + Capecitabine
  • Best supportive care
  • (no location specified)
Sep 22, 2022

Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,

Recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • ctDNA and adjuvant therapy
  • ctDNA
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 22, 2022

Metastatic Melanoma to the Groin Lymph Nodes Trial in Worldwide (Inguinal Lymphadenectomy, Ilio-inguinal Lymphadenectomy)

Active, not recruiting
  • Metastatic Melanoma to the Groin Lymph Nodes
  • Inguinal Lymphadenectomy
  • Ilio-inguinal Lymphadenectomy
  • Canberra, Australian Capital Territory, Australia
  • +16 more
Apr 6, 2022

HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

Active, not recruiting
  • HER2/Neu Negative
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
  • +1 more
Jan 11, 2022

Colorectal Cancer Stage IV, No Evidence of Disease State Trial in Genova (Durvalumab Injection for intravenous use 500 mg vial

Recruiting
  • Colorectal Cancer Stage IV
  • No Evidence of Disease State
  • Durvalumab Injection for intravenous use 500 mg vial solution for infusion
  • Regorafenib 30 mg capsules
  • Genova, Liguria, Italy
    IRCCS Ospedale Policlinico San Martino
May 16, 2022

Alzheimer, Dementia, Sleep Disorder Trial (LOCK Sleep Program, No intervention (control period/baseline data collection))

Not yet recruiting
  • Alzheimer Disease
  • +3 more
  • LOCK Sleep Program
  • No intervention (control period/baseline data collection)
  • (no location specified)
Apr 7, 2023

Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)

Recruiting
  • Squamous Cell Carcinoma
  • Standard surveillance
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022

Metastatic Colorectal Cancer: A Clinical and Patient Perspective

Active, not recruiting
  • Metastatic Colorectal Cancer
  • observational disease study
  • Buenos Aires, Argentina
  • +17 more
Jan 24, 2023

Real World Evidence of Benralizumab in Eosinophilic Severe

Recruiting
  • Severe Eosinophilic Asthma
    • Moscow, Russian Federation
      City clinical hospital No57
    Aug 8, 2022

    Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

    Not yet recruiting
    • Breast Cancer, Early Breast Cancer
    • (no location specified)
    Jul 11, 2023

    Microvascular Coronary Dysfunction Trial in Los Angeles (Handgrip, Altitude simulation, Leg exercise)

    Recruiting
    • Microvascular Coronary Dysfunction
    • Handgrip
    • +2 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Aug 17, 2021

    Neurofilaments for NEDA Assessing in MS

    Terminated
    • Multiple Sclerosis
    • London, England, United Kingdom
      Queen Mary University of London
    Feb 9, 2022

    Colorectal Cancer, Healthy, no Evidence of Disease Trial in Buffalo, New York (behavioral intervention)

    Completed
    • Colorectal Cancer
    • Healthy, no Evidence of Disease
    • behavioral intervention
    • Buffalo, New York
    • +1 more
    Jul 20, 2022

    SARS CoV 2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2, Placebo)

    Recruiting
    • SARS CoV 2 Infection
    • Recombinant NDV Vectored Vaccine for SARS-CoV-2
    • Placebo
    • Mexico City, Cdmx, Mexico
    • +3 more
    Mar 23, 2022

    No Evidence of Disease Trial in Buffalo (Clinical Observation, Flaxseed, Laboratory Biomarker Analysis)

    Completed
    • No Evidence of Disease
    • Clinical Observation
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 6, 2022

    Dysplastic Nevus, Health Status Unknown, Melanoma Trial in New Brunswick (Best Practice, mySmartCheck, Survey Administration)

    Completed
    • Dysplastic Nevus
    • +3 more
    • Best Practice
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Apr 5, 2022

    Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)

    Not yet recruiting
    • Melanoma
    • Non-small Cell Lung Cancer
    • Evaluation of ctDNA using the F1T after 1 year of immunotherapy
    • (no location specified)
    Nov 24, 2023

    Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering

    Terminated
    • Healthy, no Evidence of Disease
    • +4 more
    • light-scattering spectroscopy
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    Nov 11, 2021

    Hepatobiliary Tumors Tissue Samples Acquisition

    Recruiting
    • Hepatocellular Carcinoma
    • +7 more
    • Gene expression analysis
    • +10 more
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Jun 8, 2022

    Metastatic Solid Tumors of Metastatic Disease Trial in United States (Radiation Therapy, Systemic Therapy)

    Recruiting
    • Metastatic Solid Tumors of Metastatic Disease
    • Radiation Therapy
    • Systemic Therapy
    • Miami, Florida
    • +8 more
    Dec 6, 2022

    No Evidence of Disease, BRCA1 Syndrome, BRCA2 Syndrome Trial in Duarte, Los Angeles, Sylmar (questionnaire administration,

    Active, not recruiting
    • No Evidence of Disease
    • +4 more
    • questionnaire administration
    • +3 more
    • Duarte, California
    • +2 more
    Mar 17, 2022

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Queen Mary Hospital
    Apr 10, 2023

    Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Prostatic Neoplasm
    • abiraterone acetate in combination with prednisone
    • Homewood, Alabama
    • +44 more
    Jan 17, 2023

    Malignant Melanoma Trial in Germany (Nivolumab + Placebo, Nivolumab + Ipilimumab, Double Placebo Control)

    Completed
    • Malignant Melanoma
    • Nivolumab + Placebo
    • +2 more
    • Berlin, Germany
    • +19 more
    Dec 10, 2021

    Oligometastatic Prostate Cancer (OMPC) Trial (AAA617)

    Not yet recruiting
    • Oligometastatic Prostate Cancer (OMPC)
    • (no location specified)
    Jul 3, 2023